Edwards Lifesciences Corporation (EW) Tops Q2 EPS by 10c, Raises Outlook
Get Alerts EW Hot Sheet
Revenue Growth %: +9.6%
Financial Fact:
Basic (in dollars per share): 0.66
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Edwards Lifesciences Corporation (NYSE: EW) reported Q2 EPS of $1.24, $0.10 better than the analyst estimate of $1.14. Revenue for the quarter came in at $972.1 million versus the consensus estimate of $969.02 million.
GUIDANCE:
Edwards Lifesciences Corporation sees Q3 2018 EPS of $0.93-$1.03, versus the consensus of $1.08. Edwards Lifesciences Corporation sees Q3 2018 revenue of $900-950 million, versus the consensus of $933.98 million.
Edwards Lifesciences Corporation sees FY2018 EPS of $4.60-$4.75, versus the consensus of $4.63. Edwards Lifesciences Corporation sees FY2018 revenue of $3.5-3.9 billion, versus the consensus of $3.84 billion.
For earnings history and earnings-related data on Edwards Lifesciences Corporation (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
- Nomura Holdings (NMR) Reports In-Line Q1 EPS
- Primis Financial (FRST) Misses Q1 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!